Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


US launches strike against ISIS in northwest Nigeria
Ukraine president discusses "bringing peace closer" with US negotiators
White House to present plans for Trump's East Wing ballroom in January
Arab Parliament welcomes direct municipal elections in Somalia
Bangladesh leader considered PM frontrunner returns from exile